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Summary. — Stem-cell–based therapies involve the administration of ex-vivo–
manipulated stem cell populations with the purpose of repairing and regenerating
damaged tissues. To monitor the outcomes of stem cell therapy longitudinally re-
quires the development of non-destructive strategies that are capable of identifying
the location, magnitude, and duration of cellular survival and fate. In the field of car-
diology the existence, in murine and human heart, of primitive cells able to generate
all the different component structures of the myocardium has been recently doc-
umented. Synchrotron-Radiation–based X-Ray computed microtomography (SR-
microCT) offers great potential to address these critical issues by non-invasively
tracking the fate of the transplanted cells. In this review work, we explored the
use of SR-microCT for detection of rat Cardiac Progenitor Cells, previously labeled
with iron oxide tracers, inside the infarcted rat heart, one week after injection and
in ex vivo conditions. This work on the one side strongly contributed to understand
how and to which extent the injected cells are able to migrate and regenerate the
damaged myocardium, on the other demonstrated that microCT appears to be an
important way to investigate the cellular events involved in cardiac regeneration and
represents a promising tool for future clinical applications.
PACS 87.57.nt – Edge enhancement.
PACS 87.57.Q- – Computed tomography.
PACS 87.59.-e – X-ray imaging.
PACS 87.85.Lf – Tissue engineering.
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1. – Introduction
Computed microtomography (microCT) and in particular Synchrotron-radiation–
based computed microtomography (SR-microCT) have become in the recent years a
useful tool for the structural analyses of different types of biomaterials and constructs in
tissue engineering research. In fact, despite the fact that one of the first medical-related
research fields in microCT was the analysis of trabecular bone samples [1], the use of this
technique was quickly exploited to other areas of interest in life sciences including tissue
engineering [2]. In particular this technique, allowing to analyse biomaterials (namely
bioceramic and polimeric scaffolds) targeted for different applications in the life sciences,
often requires approaches and settings that are completely different from each other.
Stem-cell–based tissue engineering therapies involve the administration of ex-vivo–
manipulated stem cell populations with the purpose of repairing and regenerating dam-
aged or diseased tissue. Currently available methods for monitoring transplanted cells
are quite limited. To monitor the outcomes of stem cell therapy longitudinally requires
the development of non-destructive strategies that are capable of identifying the loca-
tion, magnitude, and duration of cellular survival and fate. Even in this case microCT
and in particular SR-microCT offer great potentials to address these critical issues by
non-invasively tracking the fate of the transplanted cells [3].
X-ray SR-microCT was successfully applied to investigate highly porous hydroxyap-
atite scaffolds [4], previously seeded with bone marrow stromal cells (BMSC), implanted
in an immunodeficient murine model. It was proved that it was possible by using the
microCT technique to obtain, in a non-destructive way, a quantitative analysis of tissue
engineered constructs, determining the total volume and thickness distribution of newly
formed bone into implants in a small animal model. Very recently, different ceramic scaf-
folds with high porosity were characterized [5] by using SR-microCT: the bone growth
into the tissue engineered constructs was evaluated in ex vivo conditions and at different
implantation times.
On the other side in the field of cardiology, clinical observations on the plasticity of
adult stem cells have provided new tools for understanding the pathophysiology of cardiac
diseases opening new strategies for the treatment of heart failure. Recent published
reports [5-9] have contributed to identify the possible approaches of cellular therapy to
generate new myocardium, involving systemic and local mobilization of progenitor cells.
Moreover, different research groups [10-12] have recently documented the existence, in
the adult murine and human heart, of primitive cells able to generate all the different
component structures of the myocardium.
At the tissue level of organization, microscopy techniques attempting to visualize the
tissue rebuilding process, such as light, fluorescence, scanning and transmission electron
microscopy are limited to two-dimensional (2D) local information or, otherwise, require
laborious three-dimensional (3D) reconstruction of serial sections.
A recent published report [13] comparing two 3D imaging methods—namely MRI
and microCT—for in vivo preclinical studies on rodents, argued that both techniques
require scan times that are much longer than a single respiratory or cardiac cycle. Real-
time imaging is not possible with the current state of the art, unless active control of
ventilation—that requires complex intubation of the animal—is performed. These serious
limitations related to the observation of a beating heart, do not exist in the present work,
which allows the visualization, in 3D and at high resolution (10–50 times higher than
MRI), of the injected cells, with the possibility to quantify them and observe their fate
within the myocardium one week after the injection.
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In fact just recently, Torrente et al. [14] showed that X-ray microCT offers the pos-
sibility to visualize in 3D and in ex vivo conditions, with high definition and resolution,
human CD133+ stem cells after transplantation and, therefore, opened new possibilities
for experimental stem cell research
In the study reported in ref. [15] and for which here we propose a detailed review, we
explored the use of microCT as an experimental technique with high spatial resolution
for detection of rat Cardiac Progenitor Cells (rCPCs), previously labeled with iron oxide
nanoparticles to increase the attenuation contrast, inside the infarcted rat heart, one
week after injection and in ex vivo conditions. This work on the one side strongly
contributed to understand how and to which extent the injected cells are able to migrate
and regenerate the damaged myocardium, on the other demonstrated that SR-microCT
offers the possibility of obtaining a 3D visualization of the cell spatial distribution and a
quantification of the number of cells that are able to migrate from the site of injection to
different areas of the rat heart tissue, with special reference to the infarcted myocardium.
2. – Materials and methods
2.1. Sample preparation experimental protocol . – The study population consisted of
three male Wistar rats (Rattus norvegicus) breed in the animal facility of the University
of Parma, Dept. of Pathology, age 12–14wk, weighing 350–400 g. Myocardial infarction
was produced in two rats by coronary binding of the left anterior descending coronary
artery. Another sham-operated rat was treated similarly, except that the ligature around
the coronary artery was not tied.
Cardiac Progenitor Cells (CPCs) were obtained from 3 month old Wistar rats by
Langhendorff perfusion apparatus as described in [10] with minor modifications. Daily,
microscopic observation of cultures showed the growth of two different adherent cell
populations, one with mesenchymal-like and one with monomorphic blast-like character-
istics. This latter population constituted the so-called Cardiac Progenitor Cells (CPCs)
provided by clonogenic growth and multipotency [10].
To detect homing and engraftment of the injected cells into murine hearts, CPCs were
loaded with iron oxide nanoparticles (Feridex–Poly-L-Lysine (PLL) complex composed
of Fe 25μg/ml + PLL 375 ng/ml) for 24 hours. Then, the medium was removed, CPCs
washed with phosphate buffered saline (PBS) and trypsinized to be injected.
Three weeks after coronary ligature, a left lateral thoracotomy and mechanical ven-
tilation was repeated in all animals under anaesthesia (Imalgene+Domitor). Two rats
were treated with Feridex-labeled CPCs. Specifically, 5× 105 CPCs suspended in 300μl
of IMDM+1% P/S supplemented with HGF (200 ng/ml) plus IGF-1 (200 ng/ml) were de-
livered in three regions bordering the scar. Each injection consisted of 100μl. The third
rat heart was injected with equal amounts of vehicle saline solution (PBS). Rhodamine
microspheres, 2.0μm in diameter (FluoSpheres, Molecular Probes, Eugene, USA), were
added to each solution (5% of the total injected volume) to ensure the successful injection.
One week after the CPCs injection the animals were sacrificed.
The hearts of anesthetized animals were arrested in diastole by injection of 5ml cad-
mium chloride solution (100mmol, IV) and the myocardial vasculature shortly perfused
at a physiological pressure with a heparinized PBS-solution, followed by perfusion with
10% formalin solution. The heart was then excised and placed in formalin solution (10%)
for 24 hours.
After fixation, the rat hearts were completely dried immediately before their submis-
sion to microCT analysis.
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The full investigation was approved by the Veterinary Animal Care and Use Commit-
tee of the University of Parma and conformed to the National Ethical Guidelines (Italian
Ministry of Health; D.L.vo 116, January 27, 1992) and the Guide for the Care and Use
of Laboratory Animals (NIH publication no. 85–23, revised 1996).
2.2. Synchrotron-radiation–based computed microtomography (SR-microCT). – Atten-
uation based X-ray radiographic imaging is an invaluable standard tool, used routinely
for non-destructive investigations in medicine [16, 17]. However, the use of conventional
attenuation-based X-ray microCT when investigating biological objects like hearts or
cells, is often not appropriate because these tissues show only weak absorption contrast.
On the other hand, the cross section for elastic scattering of X-rays in matter, which
causes a phase shift of the wave passing through the object of interest, is usually much
greater than that for absorption.
The in-line technique offers a very simple imaging set-up compared to other currently
available X-ray phase-contrast imaging techniques. In fact in in-line, or propagation
based, phase contrast imaging, phase contrast is achieved by simply letting the X-ray
beam propagate in free space after interaction with the object. The contrast formation
process can be understood in the framework of Fresnel diffraction [18].
When an X-ray beam passes through an object, it may be affected in two ways: it
might be absorbed in the object, which changes its amplitude, and it might be retarded
in the object, which changes its phase. For X-rays we can consider the object completely
described by the complex refractive index n = ε + ιβ. Since ε is smaller than, but close
to, unity for hard X-rays, the 3D complex refractive index distribution in the object can
be written as
n(x, y, z) = 1− δn(x, y, z) + iβ(x, y, z),(1)
where δn is the refractive index decrement, β is the attenuation index and (x, y, z) the
spatial coordinates. Both quantities δn and β are real and positive. The amplitude and
phase modulations introduced on the incident wave by the object can be described by a
transmittance function [19]
u0(x) = T (x)uinc(x),(2)
where uinc(x) is the incident wave field, u0(x) the wave field at the exit plane of the
object (D = 0), x = (x, y) are the spatial coordinates in the plane perpendicular to the
propagation direction z, and
T (x) = exp[−B(x)] exp[iϕ(x)].(3)
Both the attenuation and the phase shift induced by the object can be described as
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This means that both parts of the complex refractive index can be reconstructed by
tomographic reconstruction if amplitude and phase can be measured for different angular
settings of the sample. Phase contrast is achieved by simply recording the projections
after a displacement of the detector away from the sample.
A microCT system available at the BM05 beamline of the European Synchrotron Ra-
diation Facility (ESRF of Grenoble, France) was used in this work to non-destructively
image and quantify the 3D microstructural morphology of the investigated rat hearts.
The microCT experiment was performed with a 15 keV monochromatic X-ray beam
and a sample-to-detector distance of 25mm for the almost pure absorption-contrast and
500mm for the phase-contrast, respectively. The acquisition set-up was based on previ-
ously described [14] 3D parallel tomography. 1500 projections and a step of 0.12 degrees
were considered for each sample, with an exposure time of 1 s per projection.
3D reconstructions of the samples were obtained from the two series of 2D projections
using a 3D filtered back projection algorithm implemented at ESRF. The different phases
found in the histogram referring to the reconstruction of the in-absorption acquisition
were segmented and rendered in colour using interactive software for the 3D imaging in
order to make them more easily recognizable.
This data volume (absorption configuration) was then analysed in order to quantify
the different phases by using the implementation of the 3D mean intercept length (MIL)
method described in detail elsewhere [20, 21]. The different volumes were computed by
counting the number of pixels labeled by the algorithm that automatically separates the
different phases. The 3D MIL method was used, assuming a parallel-plate model, in
order to derive the volume of the injected cells.
Volume rendering is a 3D visualization method by which the data volumes (absorption,
phase contrast and combination of both) are rendered directly without decomposing it
into geometric primitives. A Quad-Core Processor 2.01GHz PC with 8Gb RAM and
the commercial software VGStudio MAX 1.2 were used to generate 3D images and to
visualize in 3D the phase distribution. In order to achieve optimal settings for the
image quality, we used Scatter HQ algorithm with an over sampling factor of 5.0 and
activated color rendering. Being both the acquisitions performed simultaneously, the
combining absorption and phase contrast images did not required their geometric warping
so that the corresponding image is structured correctly. Therefore, synchronization may
be interactive or partially or fully automatic with help of a fusion algorithm which is
described elsewhere [22]. The full fusion automatic algorithm was used. This exact
synchronization of data sets provides capacity for image fusion with superimposition of
both sets of imaging data in one image data set for further 3D visualization.
3. – Results
The 3D distribution of rat CPCs, one week after their injection into an infarcted
rat heart, was imaged and characterized by microCT both in absorption and in phase-
contrast configuration. Two infarcted rat hearts, both injected with 5× 105 Feridex-
labeled stem cells, were analyzed one week after CPCs injection. A third rat heart, not
infarcted, injected only with the vehicle saline solution containing rhodamine particles
was also investigated and considered as control.
The harvested heart samples were scanned and projection data were collected and
processed to obtain a series of 2D images (stack of slices) of the hearts. Some representa-
tive reconstructed 2D slices, referred to an infarcted heart apex, are shown in fig. 1a and
fig. 1b. The basic physical parameter quantified in each pixel of an absorption microCT
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Fig. 1. – (A,B) Reconstructed 2D slices of a representative infarcted rat heart corresponding to
axial sections at the level of the infarct. The infarcted area is well identifiable in the external
wall of the left ventricle, where the wall is macroscopically thinner than the right ventricle and
septum walls. The X-ray attenuation produced by the labeled CPCs is higher than attenuation
referred to the other tissues, allowing their visualization as bright spots in the injured area.
(C) The histogram of the grey level scale corresponding to the different detected phases [15].
(D) Magnification of the portion of the histogram shown in (C) referred to the peak correspond-
ing to the labeled cells grey level [15].
slice is the linear X-ray attenuation coefficient μ. The X-ray attenuation produced by
the Feridex-labeled transplanted CPCs is higher than attenuation produced by the my-
ocardium of the injected hearts, allowing their visualization as bright spots in the 2D
images (white spots in fig. 1a and fig. 1b). Different phases produce different X-Ray
absorption rate within the samples that, in turn, translate into different peaks in the
grey level scale. The histogram of the grey level scale is shown in fig. 1c and fig. 1d. The
volume of each phase is obtained by multiplying the volume of a voxel (around 125μm3)
by the number of voxels underlying the peak associated with the specific phase. In the
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Fig. 2. – (A) 3D full reconstruction of a representative CPC-treated rat heart obtained by
combination of absorbtion and phase-contrast signals (fusion method). (B) The segmentation
process provides information on the distribution of labeled CPCs [15].
infarcted rat hearts, in agreement with the amount of the injected CPCs, their volume
percentage with respect to the total investigated volume is very low. This fact explains
why the peak corresponding to the labeled CPCs cannot be revealed in fig. 1c but,
magnifying the respective portion of the histogram, it can be easily visualized in fig. 1d.
The slices were compiled in a stack to render 3D reconstructions of the investigated
rat hearts with the aim to obtain a realistic volumetric visualization of the stem cell
distribution after their injection in the infarcted rat hearts.
3D images obtained combining absorption and phase-contrast signal using the fusion
technique are represented in fig. 2. In combined imaging, morphological information
about heart tissue from phase contrast (fig. 2a) is complemented and extended by the
functional information on labeled-CPCs supplied from absorption mode. In fact, the
simple segmentation of the histogram referred to the set of data produced with the
absorption set up provides information on the internal structure of the heart and the
distribution of the CPCs within it (fig. 2b). In particular in fig. 2 all the phases of
the rat heart were represented. Processing the 3D image of the heart it is also possible
to make one or more phases translucent or even to “cancel” a phase in order to allow
a more accurate observation of the spatial distribution of each phase. In fig. 2b we
virtually deleted the heart tissue phase for a better visualization of the labeled CPCs in
the different areas of the rat heart.
No dramatic difference in the location of stem cells was observed in the two infarcted
hearts: the percentage of migrated labeled stem cells from the injection area to the in-
farcted area or towards other areas was calculated by counting their corresponding pixels,
using the algorithm that automatically separates them from the other tissues [15]. No
detectable spots were found in the rat heart injected with only the vehicle saline solution
containing rhodamine particles, demonstrating that the bright spots in the cell-treated
infarcted hearts correspond to labeled CPCs. Portions of the 3D reconstruction referred
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Fig. 3. – MicroCT 3D reconstructions of the not-infarcted heart injected with only the vehicle
saline solution containing rhodamine particles. LV: left ventricle; RV: right ventricle; S: septum.
(A, C) Two 3D portions of the bottom part of the heart corresponding to the apex largely
involved by infarction in the other infarcted hearts. (B,D) Same volumes as in (A) and (C),
respectively—all the phases were virtually made transparent beside the portion of the histogram
corresponding to the labeled cells in the infarcted hearts. No cells are visible both in the right
and left ventricle.
to the control rat heart (lower part corresponding to the infarcted area in the two CPC-
treated hearts) are represented in fig. 3. Figure 3b and fig. 3d demonstrate that, after
the same 3D image processing (segmentation) used for the infarcted hearts, no bright
signals can be found in this control sample.
4. – Discussion
The main interest in combining phase imaging to attenuation-based microCT is the
improved sensitivity the former offers compared to the latter. The gain in sensitivity
in the hard–X-ray range can be several orders of magnitude for soft materials, which
makes it appealing for biomedical imaging of soft tissues, including studies of adult
autologous cellular therapy for the treatment of acute and chronic myocardial infarction.
On the other hand, many unresolved questions limit at the moment the challenge to
link experimental with clinical observations, concerning the fate of transplanted stem
cells in the recipient tissue and the specific tracing of engrafted cells or cell populations
detectable by imaging techniques.
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Fig. 4. – 3D image of the infarcted area obtained with the fusion method [15]. Two different
structures have been individuated: a rounded-shape one, typical for the CPCs also in the original
in vitro cultures, and the other made of oriented rod-shaped structures, most likely cells grouped
in finger-like clusters.
In ref. [15] the microCT was used to image and characterize the 3D spatial distribution
of injected rat clonogenic cells (CPCs) after their labeling by iron oxide nanoparticles,
inside the heart tissue of infarcted rats. The 3D visualization of the spatial distribution
of the injected CPCs with respect to myocardium was obtained. In particular, being
the X-ray attenuation produced by the labeled cells higher than that of host myocardial
tissues, we achieved their visualization as bright spots both in the 2D slices (fig. 1a
and fig. 1b) and in the whole 3D reconstructions (fig. 2). One week after injection,
labeled cells were distributed mostly in proximity and towards the damaged infarcted
area (fig. 2b), demonstrating migration of CPCs from the injection site towards the
injured myocardium. Structures with two different morphologies were detected: one
rounded-shaped, typical for the CPCs also in the original in vitro cultures, and the other
made of oriented rod-shaped structures, likely cells grouped in finger-like clusters (fig. 4).
This is a very useful piece of information not detectable by conventional histological
methods. We also observed single cell units in all areas of the heart, as in the atria,
in large vessels and in the right ventricle (fig. 2b), confirming that the injected CPCs
can migrate through the myocardium by biological mechanisms that are still not fully
understood.
The fact that no X-ray absorption contrast was found within the rat heart injected
with only saline solution and rhodamine particles suggests that microCT is able to detect
at 3D level and at high resolution the migrating labeled cells.
Furthermore these microCT results are in close agreement with the imaging of the dis-
tribution of QDots-labeled CPCs injected in identically treated infarcted rat hearts [15].
Also this fact suggests the validity of the microCT to detect cell migration and engraft-
ment within the injured heart.
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On the other hand, the issue whether either iron particles, as detected here by Mi-
croCT, or QDots nanoparticles, as detected by UV excitation, could only represent un-
reliable signals of macrophages uptaking tracers released by dying cells, remains an un-
resolved problem especially on clinical ground. Because of that, in ref. [15] a third
independent genetic marker was applied to visualize the progeny of the injected cells.
This approach allowed us to ensure that the progeny of the injected cells was present in
the infarcted heart and with a similar distribution to that observed with QDots labeling
and MicroCT imaging. Importantly, by this third genetic-marker–based approach, the
differentiation of CPCs into cardiomyocytes was also demonstrated. This induced the
authors of ref. [15] to estimate, by quantitative analysis of the microCT data, the total
number N of the cells found in the hearts one week after CPC injection.
By this quantitative analysis, they found out that in both the infarcted hearts the
number N of CPC-derived cells is more than doubled with respect to the number of in-
jected CPCs, demonstrating that, at least for labeled CPCs and at a week from injection,
the presence of iron oxide nanoparticles does not dramatically affect the CPC fate.
However it has to be stressed that, before the introduction of the available imaging
methodologies, including microCT, in the clinical practise, it is necessary to clarify several
issues. For instance, at which extent the microCT in absorption configuration is able to
detect the injected cells even after their proliferation with the consequent hyperdilution
(possibly below the detection limit) of the iron oxide tracer on dividing cells.
Further follow-up studies are required to explore the potentialities in this field of
the in-line, or propagation-based, phase contrast imaging. In fact, the main interest
in phase imaging is the improved sensitivity it offers compared to attenuation-based
techniques [18]. The gain in sensitivity in the hard–X-ray range can be several orders of
magnitude for soft materials, even in the absence of any tracer, which makes it appealing
for biomedical imaging of soft tissues, including stem-cell–treated infarcted hearts. The
possibility to perform in-line microCT investigation in soft tissues, without the need of
any contrast agent, would provide new insights not only in the imaging of soft tissues and
cells but also, in cardiology, would achieve the possibility to study remote time points
after cell injection, definitively avoiding the possibility that bright spots in 3D microCT
images represent macrophages that have phagocytized iron nanoparticles, or highly
absorbent particles that have been expelled from injected cells into the interstitium.
In conclusion, the 3D images produced in ref. [15] represent a very innovative progress,
as compared to the usual 2D histological images, which do not provide the overall 3D
distribution of the injected stem cells within the heart. Furthermore, these observations
strongly support further studies aiming to support the contention that phase contrast
microCT represents a new 3D-imaging way to investigate the cellular events involved in
cardiac regeneration and represents a promising tool for other applications in regenerative
medicine.
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